Marcos Wolf

Dr. Marcos Wolf

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2018 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
NSNicholas M Selby
Nicholas M Selby
PBPeter J Blankestijn
Peter J Blankestijn
PBPeter Boor
Peter Boor
CCChristian Combe
Christian Combe
KEKai-Uwe Eckardt
Kai-Uwe Eckardt
SSSteven Sourbron
Steven Sourbron
Functional renal magnetic resonance imaging (MRI) has seen a number of recent advances, and techniques are now available that can generate quantitative imaging biomarkers with the potential to improve the management of kidney disease. Such biomarkers are sensitive to changes in renal blood flow, tissue perfusion, oxygenation and microstructure (including inflammation and fibrosis), processes that are important in a range of renal diseases including chronic kidney disease. However, several challenges remain to move these techniques towards clinical adoption, from technical validation through biological and clinical validation, to demonstration of cost-effectiveness and regulatory qualification. To address these challenges, the European Cooperation in Science and Technology Action PARENCHIMA was initiated in early 2017. PARENCHIMA is a multidisciplinary pan-European network with an overarching aim of eliminating the main barriers to the broader evaluation, commercial exploitation and clinical use of renal MRI biomarkers. This position paper lays out PARENCHIMA’s vision on key clinical questions that MRI must address to become more widely used in patients with kidney disease, first within research settings and ultimately in clinical practice. We then present a series of practical recommendations to accelerate the study and translation of these techniques.

23 August 2018 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
MWMarcos Wolf
Marcos Wolf
ABAnneloes de Boer
Anneloes de Boer
KSKanishka Sharma
Kanishka Sharma
PBPeter Boor
Peter Boor
TLTim Leiner
Tim Leiner
NJNeil Peter Jerome
Neil Peter Jerome
This systematic review, initiated by the European Cooperation in Science and Technology Action Magnetic Resonance Imaging Biomarkers for Chronic Kidney Disease (PARENCHIMA), focuses on potential clinical applications of magnetic resonance imaging in renal non-tumour disease using magnetic resonance relaxometry (MRR), specifically, the measurement of the independent quantitative magnetic resonance relaxation times T1 and T2 at 1.5 and 3Tesla (T), respectively. Healthy subjects show a distinguishable cortico-medullary differentiation (CMD) in T1 and a slight CMD in T2. Increased cortical T1 values, that is, reduced T1 CMD, were reported in acute allograft rejection (AAR) and diminished T1 CMD in chronic allograft rejection. However, ambiguous findings were reported and AAR could not be sufficiently differentiated from acute tubular necrosis and cyclosporine nephrotoxicity. Despite this, one recent quantitative study showed in renal transplants a direct correlation between fibrosis and T1 CMD. Additionally, various renal diseases, including renal transplants, showed a moderate to strong correlation between T1 CMD and renal function. Recent T2 studies observed increased values in renal transplants compared with healthy subjects and in early-stage autosomal dominant polycystic kidney disease (ADPKD), which could improve diagnosis and progression assessment compared with total kidney volume alone in early-stage ADPKD. Renal MRR is suggested to be sensitive to renal perfusion, ischaemia/oxygenation, oedema, fibrosis, hydration and comorbidities, which reduce specificity. Due to the lack of standardization in patient preparation, acquisition protocols and adequate patient selection, no widely accepted reference values are currently available. Therefore this review encourages efforts to optimize and standardize (multi-parametric) protocols to increase specificity and to tap the full potential of renal MRR in future research.

17 December 2024 in Sensors
Verified
Journal Article
Open access
PDF file
ODOmar Darwish
Omar Darwish
VKVitali Koch
Vitali Koch
Thomas Josef VoglThomas Josef Vogl
Thomas Josef Vogl
MWMarcos Wolf
Marcos Wolf
KSKatharina Schregel
Katharina Schregel
RSRalph Sinkus
Ralph Sinkus
MR elastography is a non-invasive imaging technique that provides quantitative maps of tissue biomechanical properties, i.e., elasticity and viscosity. Currently, hepatic MR elastography is deployed in the clinic to assess liver fibrosis in MAFLD patients. In addition, research has demonstrated MR elastography’s ability to non-invasively assess chronic liver disease and to characterize breast cancer lesions and brain tumors. MR elastography requires efficient mechanical wave generation and penetration, motion-sensitized MRI sequences, and MR elastography inversion algorithms to retrieve the biomechanical properties of the tissue. MR elastography promises to enable non-invasive and versatile assessment of tissue, leading to better diagnosis and staging of several clinical conditions.

18 November 2023
Verified
Book Chapter
Closed access
PDF file
MWMarcos Wolf
Marcos Wolf
DBDiana Bencikova
Diana Bencikova
EMEwald Moser
Ewald Moser

8 June 2026 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
LKLorenz Kiss
Lorenz Kiss
JGJean-Lynce Gnanago
Jean-Lynce Gnanago
SWStefan Wampl
Stefan Wampl
MWMarcos Wolf
Marcos Wolf
CBChristopher Breitenfelder
Christopher Breitenfelder
ASAlbrecht Ingo Schmid
Albrecht Ingo Schmid
Magnetic Resonance Elastography (MRE) can be used to estimate biomechanical parameters, e.g., shear stiffness of human tissue. As such, it is an imaging-based extension of palpation. To perform MRE, mechanical waves are induced into the tissue by transducers or actuators. The resulting periodic microscopic tissue displacements are recorded using phase-contrast magnetic resonance imaging (MRI). Good transducers need sufficient vibration amplitudes and frequency stability with little contributions of higher order harmonics. For clinical use, it needs to be compact for comfort as well as interference with RF coil placement. Safe operation in strong electromagnetic fields is a must. Setup procedures should be simple and quick. Here, a new compact pneumatically driven gravitational transducer (CPT) for MR elastography is presented. It consists of rotating unbalances stacked on either side of a turbine. Additional insertable masses allow adjustment of the vibration amplitude at a set frequency. Additive manufacturing and milling were combined to produce the transducer. The flat design of the CPT allows for placement between body and receiver coil with minimal sensitivity loss in most relevant targets. PID control is used to precisely control vibration frequency, based on optical detection of rotation cycles. It adjusts a valve in the air supply of the turbine. It is constructed using non-magnetic, non-conducting materials, which makes it inherently MRI-safe. The electronics, fittings and valves are placed in a control unit (CU) outside the magnet room. A hose and two optical fibres connect the transducer and the CU. The performance of the transducer was thoroughly bench tested and phantom experiments in the MRI scanner demonstrated the feasibility and robustness of the system. The frequency control was excellent for a pneumatic system (FWHM 0.04-0.20 Hz) across a wide range (50-130 Hz), while amplitudes of higher harmonics are very low (1.9-8.1 % 1st, 0.2-4.6 % 2nd order). Imaging data confirm that the CPT generated displacements which could be recorded with MR elastography pulse sequences. In conclusion, we present a new MRE pneumatically driven gravitational transducer, Its advantages are the combination of the following features: It requires no electrical components in the vicinity of the MR scanner. It performs equally well as electromechanically driven systems while it outperforms pneumatic designs in terms of frequency stability. Its compact design allows for flexibility in placement with a variety of RF coils and target tissues in the body. It consists of low-cost components and is easily used. We conclude that the combination of the CPT’s features constitute a substantial improvement in MRE transducer design.